玉屏风散合补中益气汤联合鼻喷激素药物治疗小儿腺样体肥大临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R729

基金项目:


Clinical Study on Yupingfeng Powder Combined with Buzhong Yiqi Tang and Nasal Spray Hormone Medicine for Adenoid Hypertrophy in Children
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察玉屏风散合补中益气汤加减联合糠酸莫米松鼻喷雾剂治疗肺脾气虚型小儿腺样体肥大的效果。方法:将84 例肺脾气虚型腺样体肥大患儿按随机数字表法分为研究组和对照组各42 例。对照组采用糠酸莫米松鼻喷雾剂治疗,研究组在糠酸莫米松鼻喷雾剂基础上采用玉屏风散合补中益气汤加减方治疗。2 组均治疗4 周。比较2 组的临床疗效,治疗前后评定中医证候积分(鼻塞、打鼾、张口呼吸、伴随症状及总积分),观察腺样体电子内镜分度结果及细胞功能指标的改善情况,统计2 组不良反应的发生情况。结果:治疗4 周后,研究组临床疗效总有效率为90.48%,高于对照组的73.81%,差异有统计学意义(P<0.05)。2 组鼻塞、打鼾、张口呼吸积分及伴随症状积分、总积分均较治疗前降低(P<0.05);研究组各项症状积分及总积分均低于对照组(P<0.05)。2 组腺样体肿大情况均得到改善(P<0.05),且研究组腺样体肿大情况的改善情况优于对照组(P<0.05)。研究组CD4+水平、CD4+/CD8+比值均较治疗前降低(P<0.05),IgG、IgA 水平均较治疗前升高(P<0.05);对照组治疗前后4 项指标值比较,差异均无统计学意义(P>0.05)。研究组CD4+水平、CD4+/CD8+比值均低于对照组(P<0.05),IgA水平高于对照组(P<0.05)。2 组患儿均未出现与治疗相关的严重不良反应。结论:玉屏风散合补中益气汤加减方联合糠酸莫米松鼻喷雾剂治疗小儿腺样体肥大疗效显著,能够明显缓解患儿的临床症状,缩小腺样体,改善患儿的免疫功能,治疗效果明确,安全可靠。

    Abstract:

    Abstract: Objective: To observe the effect of Yupingfeng powder combined with modified Buzhong Yiqi tang and mometasone furoate aqueous nasal spray on adenoid hypertrophy of lung-spleen qi deficiency type in children. Methods:A total of 84 children with adenoidal hypertrophy of lung- spleen qi deficiency type were divided into the study group and the control group according to the random number table method, with 42 cases in each group. The control group was treated with mometasone furoate aqueous nasal spray, and the study group was additionally treated with Yupingfeng powder combined with modified Buzhong Yiqi tang based on the treatment of mometasone furoate aqueous nasal spray. Both groups were treated for four weeks. The clinical effects in the two groups were compared. Before and after treatment,the Chinese medicine syndrome scores, including the scores of nasal congestion, snoring, breathing with the mouth open and accompanying symptoms and total scores,were evaluated. The results of adenoid endoscopic grading and the improvement of cell function indexes were observed. The incidence of adverse reactions in the two groups was counted. Results:After four weeks of treatment,the total clinical effective rate was 90.48% in the study group,higher than that of 73.81% in the control group,the difference being significant(P<0.05). The scores of nasal congestion,snoring,breathing with the mouth open, accompanying symptoms and total scores in the two groups were decreased when compared with those before treatment (P<0.05); the above scores in the study group were lower than those in the control group(P<0.05). Adenoid hypertrophy in the two groups was improved(P<0.05),and the improvement of adenoid hypertrophy in the study group was better than that in the control group(P<0.05). The level of CD4 + and ratio of CD4 +/CD8 + in the study group were decreased when compared with those before treatment(P<0.05),and the levels of lgG and lgA were increased(P<0.05);there was no significant difference being found in the comparison of the above four indexes in the control group before and after treatment (P>0.05). The level of CD4+ and ratio of CD4+/CD8+ in the study group were lower than those in the control group(P<0.05), the level of IgA was higher than that in the control group(P<0.05). During treatment,no serious adverse reactions that related to the treatment were found in both groups. Conclusion: The therapy of Yupingfeng powder combined with modified Buzhong Yiqi tang and mometasone furoate aqueous nasal spray has a significant curative effect on adenoid hypertrophy in children,which can significantly alleviate the clinical symptoms of children,reduce the adenoids and improve the immune function of children,with a definite curative effect and great safety.

    参考文献
    相似文献
    引证文献
引用本文

冯娟,石海莎,张娟,郑卢军.玉屏风散合补中益气汤联合鼻喷激素药物治疗小儿腺样体肥大临床研究[J].新中医,2022,54(6):62-67

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-03-25
  • 出版日期:
文章二维码